Neochem Bio Solutions Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Neochem Bio Solutions Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹98
Per ShareLot Size
1200 Shares
Minimum Investment
₹1,17,600
Issue Size
₹44.97 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Neochem Bio Solutions Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
91.12%
Promoter Holding (Post-Issue)
66.7%
Issue Type
Book Building - SME
ISIN
INE21UM01018
About the Company
We are a specialty performance chemical company with a legacy of over four decades, engaged in the business of manufacturing specialty performance chemicals with a diverse portfolio of over 350 customized formulations across four primary product segments such as (i) Polymers, (ii) Surfactants, (iii) Silicones, and (iv) Esters & bio-based sustainable solutions. Our products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments. Our Company is accredited with ISO 9001:2015, ISO 14001 and ISO 45001. Our product certifications include ZDHC Level 3 and GOTS 7.0.
Industry Overview
The global chemicals industry was valued at approximately $5.7 trillion in 2023, contributing around 7% to global GDP. The industry is estimated to have been valued at $5.9 trillion in 2024. The industry has grown at a CAGR of 7% from 2014 to 2024 and is projected to grow at 7%, reaching nearly $8.3 trillion by 2029. The Indian specialty chemicals market has demonstrated robust growth, expanding from Rs 2.2 lakh crore in FY19 to an estimated Rs 5 lakh crore in FY25, and is projected to reach Rs 7.5 lakh crore by FY29, registering a CAGR of 10-12% over the next four years.
Company History
Our Company was originally formed as a partnership firm under the Indian Partnership Act, 1932 ("Partnership Act") in the name and style of "Vinayak Dyes & Chemical Industries", pursuant to Deed of Partnership dated March 6, 1978 .Vinayak Dyes & Chemical Industries was changed to "Neochem Technologies" with effect from January 6, 2006 and further the firm was converted from Partnership Firm to Private Limited company under Part I chapter XXI of the Companies Act, 2013 and received a Certificate of Incorporation from Registrar of Companies, Ahmedabad at Gujarat ("RoC") on June 6, 2017 as "Neochem Technologies Private Limited". Furthermore, the name of our Company was changed from Neochem Technologies Private Limited to Neochem Bio Solutions Private Limited and Certificate of Name change dated March 18, 2025 was received by the Company. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed by our shareholders resolution dated March 26, 2025, and the name of our Company was changed to "Neochem Bio Solutions Limited". A fresh certificate of Incorporation consequent upon conversion from a Private Limited company to Public Limited company dated April 15, 2025 was issued by the Registrar of Companies, Central Processing Centre.
Products & Services
- The Company is a specialty performance chemical company with a legacy of over four decades, engaged in the business of manufacturing specialty performance chemicals with a diverse portfolio.
Growth Strategy
- Strengthening our presence across end-user application industries.
- Commitment to continuous development of performance chemistries and sustainable solutions.
- Continued focus on expansion of geographical presence.
- Leverage existing strategic collaborations and partnerships to diversify end user industries.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public issue of upto 45,88,800 equity shares of face value of Rs.10/- each of Neochem Bio Solutions Limited (formerly known as Neochem Bio Solutions Private Limited & Neochem Technologies Private Limited), ("Neochem" or the "company" or the "issuer") for cash at a price of Rs.98/- per equity share including a share premium of Rs.88/- per equity share (the "issue price") aggregating to Rs.44.97 crores ("the issue"), of which 2,32,800 equity shares of face value of Rs.10/- each for cash at a price of Rs.98/- per equity share including a share premium of Rs.88/- per equity share aggregating to Rs.2.28 crores will be reserved for subscription by market maker to the issue (the "market maker reservation portion"). The issue less the market maker reservation portion i.e. net issue of 43,56,000 equity shares of face value of Rs.10/- each at a price of Rs. 98/- per equity share including a share premium of Rs.88/- per equity share aggregating to Rs.42.69 crores is hereinafter referred to as the "net issue". The issue and the net issue will constitute 26.80% and 25.44%, respectively, of the post issue paid up equity share capital of the company.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Integrated and flexible manufacturing operations for sustainable formulations enabling customized supply.
- Strong understanding of applied chemistries for diverse end-use industries.
- Established long-standing relationships with customers across end-use industries.
- Research and development (R&D) capabilities for development of innovative performance chemistries.
- Established sales and distribution network.
- The company derive a substantial portion of its revenue from the textile industry. Consequently, any material decline in the performance of the textile sector, or the company failure to sustain, grow, or efficiently manage the company sales within this sector, may materially and adversely affect its business operations, financial condition and results of operations.
- The Company derives revenue from diversified customers. Its inability to acquire new customers or loss of all or a substantial portion of any of the company major customers, for any reason and/or continued reduction of the business from them, could have a material adverse impact on its business, results of operations, cash flows and financial condition.
- The company does not maintain long-term contractual arrangements with the majority of the customers. As a result, the loss of one or more key customers, or any significant reduction in their demand for the companies products, could materially and adversely affect its business operations, financial condition, results of operations and cash flows.
- Under utilization of the installed capacities at the Company may have an adverse impact on its growth and future profitability.
- The company derives a significant portion of its revenue from operations from domestic sales which exposes it to risks specific to Indian geographies and market.